It looked to be a very strong quarter. I'm surprised by how strong the HIV franchise was.
It's clear that there is an increased investor focus, government focus and public focus on anything to do with infectious diseases, particularly flu.
It's not necessary to sell the company, they could to a (licensing) deal.
Right now it's probably the fastest growing drug sector.
The stock has gotten a lot cheaper.
There are several drivers for potential earnings growth that I don't think are reflected in the stock.
We believe continued strong oncology sales and operational execution will sustain the premium multiple versus the peer group.
We remain cautious until we see significant evidence of accelerating sales, operational and commercial execution, and improved long-term visibility on sales and earnings growth.
You're in your 40s and you've got breast cancer, but everybody in your family has died of a heart attack. It's clear that for the appropriate people this is going to be the appropriate treatment.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.